Chrysostomou, C., Lichtenstein, S. E., Jooste, E. H., Callahan, P., Suresh, T., Beerman, L., … Sanchez-de-Toledo, J. (2010). Perioperative Use of the Alpha-2 Adrenergic Agonist Dexmedetomidine, Reduces the Incidence of Supraventricular and Ventricular Tachyarrhythmias in Patients Undergoing Congenital Cardiac Surgery. CIRCULATION, 122(21).

Chrysostomou, Constantinos, Steven E. Lichtenstein, Edmund H. Jooste, Patrick Callahan, Tunga Suresh, Lee Beerman, Dana Shiderly, et al. “Perioperative Use of the Alpha-2 Adrenergic Agonist Dexmedetomidine, Reduces the Incidence of Supraventricular and Ventricular Tachyarrhythmias in Patients Undergoing Congenital Cardiac Surgery.” CIRCULATION 122, no. 21 (November 23, 2010).

Chrysostomou C, Lichtenstein SE, Jooste EH, Callahan P, Suresh T, Beerman L, et al. Perioperative Use of the Alpha-2 Adrenergic Agonist Dexmedetomidine, Reduces the Incidence of Supraventricular and Ventricular Tachyarrhythmias in Patients Undergoing Congenital Cardiac Surgery. CIRCULATION. 2010 Nov 23;122(21).

Chrysostomou, Constantinos, et al. “Perioperative Use of the Alpha-2 Adrenergic Agonist Dexmedetomidine, Reduces the Incidence of Supraventricular and Ventricular Tachyarrhythmias in Patients Undergoing Congenital Cardiac Surgery.” CIRCULATION, vol. 122, no. 21, LIPPINCOTT WILLIAMS & WILKINS, Nov. 2010.

Chrysostomou C, Lichtenstein SE, Jooste EH, Callahan P, Suresh T, Beerman L, Shiderly D, Omalley E, Orr R, Yoshida M, Wearden P, Morell VO, Munoz R, Sanchez-de-Toledo J. Perioperative Use of the Alpha-2 Adrenergic Agonist Dexmedetomidine, Reduces the Incidence of Supraventricular and Ventricular Tachyarrhythmias in Patients Undergoing Congenital Cardiac Surgery. CIRCULATION. LIPPINCOTT WILLIAMS & WILKINS; 2010 Nov 23;122(21).